129 related articles for article (PubMed ID: 21402717)
21. Tissue plasminogen activator modulates emotion in a social context.
Nakamura K; Takabe A; Shimizu F; Takahashi M; Matsuo O; Mitsui S
Behav Brain Res; 2015 Mar; 281():24-31. PubMed ID: 25499620
[TBL] [Abstract][Full Text] [Related]
22. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.
Marubio LM; del Mar Arroyo-Jimenez M; Cordero-Erausquin M; Léna C; Le Novère N; de Kerchove d'Exaerde A; Huchet M; Damaj MI; Changeux JP
Nature; 1999 Apr; 398(6730):805-10. PubMed ID: 10235262
[TBL] [Abstract][Full Text] [Related]
23. Impaired passive avoidance learning in mice lacking central neuronal nicotinic acetylcholine receptors.
Marubio LM; Paylor R
Neuroscience; 2004; 129(3):575-82. PubMed ID: 15541879
[TBL] [Abstract][Full Text] [Related]
24. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
[TBL] [Abstract][Full Text] [Related]
25. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
Quik M; Vailati S; Bordia T; Kulak JM; Fan H; McIntosh JM; Clementi F; Gotti C
Mol Pharmacol; 2005 Jan; 67(1):32-41. PubMed ID: 15470079
[TBL] [Abstract][Full Text] [Related]
26. Chronic neonatal nicotine upregulates heteromeric nicotinic acetylcholine receptor binding without change in subunit mRNA expression.
Huang LZ; Winzer-Serhan UH
Brain Res; 2006 Oct; 1113(1):94-109. PubMed ID: 16942759
[TBL] [Abstract][Full Text] [Related]
27. Prefrontal neuromodulation by nicotinic receptors for cognitive processes.
dos Santos Coura R; Granon S
Psychopharmacology (Berl); 2012 May; 221(1):1-18. PubMed ID: 22249358
[TBL] [Abstract][Full Text] [Related]
28. Nicotinic acetylcholine receptor distribution in relation to spinal neurotransmission pathways.
Khan I; Osaka H; Stanislaus S; Calvo RM; Deerinck T; Yaksh TL; Taylor P
J Comp Neurol; 2003 Dec; 467(1):44-59. PubMed ID: 14574679
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
Whiteaker P; Jimenez M; McIntosh JM; Collins AC; Marks MJ
Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
[TBL] [Abstract][Full Text] [Related]
30. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.
Damaj MI; Fonck C; Marks MJ; Deshpande P; Labarca C; Lester HA; Collins AC; Martin BR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1161-9. PubMed ID: 17371806
[TBL] [Abstract][Full Text] [Related]
31. Exploratory activity and a conditioned fear response: correlation with cortical and subcortical binding of the alpha4beta2 nicotinic receptor agonist [3H]-epibatidine.
Sienkiewicz-Jarosz H; Maciejak P; Bidziński A; Szyndler J; Siemiatkowski M; Członkowska A; Lehner M; Płaźnik A
Pol J Pharmacol; 2003; 55(1):17-23. PubMed ID: 12856821
[TBL] [Abstract][Full Text] [Related]
32. Regulated expression of neuronal SIRT1 and related genes by aging and neuronal β2-containing nicotinic cholinergic receptors.
Huang PS; Son JH; Abbott LC; Winzer-Serhan UH
Neuroscience; 2011 Nov; 196():189-202. PubMed ID: 21939740
[TBL] [Abstract][Full Text] [Related]
33. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
[TBL] [Abstract][Full Text] [Related]
34. Olfactory cues increase avoidance behavior and induce Fos expression in the amygdala, hippocampus and prefrontal cortex of socially defeated mice.
Bourne AR; Mohan G; Stone MF; Pham MQ; Schultz CR; Meyerhoff JL; Lumley LA
Behav Brain Res; 2013 Nov; 256():188-96. PubMed ID: 23968590
[TBL] [Abstract][Full Text] [Related]
35. Postnatal upregulation of alpha4 and alpha3 nicotinic receptor subunits in the brain of alpha7 nicotinic receptor-deficient mice.
Yu WF; Guan ZZ; Nordberg A
Neuroscience; 2007 Jun; 146(4):1618-28. PubMed ID: 17434683
[TBL] [Abstract][Full Text] [Related]
36. Nicotinic receptors in mouse prefrontal cortex modulate ultraslow fluctuations related to conscious processing.
Koukouli F; Rooy M; Changeux JP; Maskos U
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14823-14828. PubMed ID: 27911815
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
Meyers EE; Loetz EC; Marks MJ
Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
[TBL] [Abstract][Full Text] [Related]
38. beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice.
Davis JA; Gould TJ
Psychopharmacology (Berl); 2007 Feb; 190(3):343-52. PubMed ID: 17136517
[TBL] [Abstract][Full Text] [Related]
39. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
[TBL] [Abstract][Full Text] [Related]
40. Effect of novel negative allosteric modulators of neuronal nicotinic receptors on cells expressing native and recombinant nicotinic receptors: implications for drug discovery.
González-Cestari TF; Henderson BJ; Pavlovicz RE; McKay SB; El-Hajj RA; Pulipaka AB; Orac CM; Reed DD; Boyd RT; Zhu MX; Li C; Bergmeier SC; McKay DB
J Pharmacol Exp Ther; 2009 Feb; 328(2):504-15. PubMed ID: 18984653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
